The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Biotech firms rush to enter CRISPR crop market to meet global food demand

| | April 19, 2019

Agriculture technology (“agtech”) companies of all sizes are vying to enter commercial food markets. [In March] when news broke about the first successful food made with a gene-edited crop, some suggested this new technology could leave genetically modified foods (along with their controversies and regulations) “in the dust.” Various stories focused on the startup Calyxt’s first commercial sale of Calyno high oleic soybean oil to the foodservice industry.

Related article:  Japan poised to permit gene editing on human embryos by 2019

Now, the commercialization of gene-edited foods (or as Calyxt dubs it, “concept to fork”) is one step closer to reality.

Why is the race on to advance gene-edited food for commercial purposes? Dr. Oliver Peoples, CEO of Yield10 Bioscience, a player in this evolving field, explained in an interview with TriplePundit:

“Enhancing global food security through improved seed yield and crop resilience is key to ensuring we’re able to produce enough food and feed, using the space and resources that we have available.”

Yield10 says it has been working to improve seed yield in commercial oilseed crops to tap into emerging market opportunities and address unmet needs for global food security….

Read full, original article: Gene-Edited Foods Just Took a Big Step Toward Commercialization

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend